Autoimmune Diseases Clinical Trials

ReadTheTrial indexes 3 studies for Autoimmune Diseases. The most common development stage is N/A (2 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

3 clinical trials found for Autoimmune Diseases.

Pipeline by Phase

PhaseTrialsDistribution
N/A 2
67%
Phase 1 1
33%

Trial Status Breakdown

Trials for Autoimmune Diseases

Deciphering the Genetic Architecture of Autoimmune Diseases

NCT06948110 · RECRUITING · N/A

An Exploratory Clinical Study Evaluate the Safety and Efficacy of Universal Universal Allogeneic CAR-T Cells Targeting CD19 and BCMA in the Treatment of B Cell-Related Autoimmune Disease

NCT07507201 · RECRUITING · Phase 1

Prospective Study of Incidence and Risk Factors of Infections and of Replacement Therapy With Intravenous Immunoglobulins for Secondary Immunodeficiency in Patients With Autoimmune Diseases Treated With Rituximab

NCT03778840 · COMPLETED · N/A

Frequently Asked Questions

What clinical trials are available for Autoimmune Diseases?

There are 3 clinical trials listed for Autoimmune Diseases. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Autoimmune Diseases trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Autoimmune Diseases trials in?

Current Autoimmune Diseases trials are distributed across: N/A (2), Phase 1 (1).

Find More Trials